Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDResearch in context

Summary: Background: Immunocompromised patients with primary and secondary immunodeficiencies have shown impaired responses to SARS-CoV-2 mRNA vaccines, necessitating recommendations for additional booster doses. However, longitudinal data reflecting the real-world impact of such recommendations re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Yu Gao, Gunnar Söderdahl, Anders Österborg, C.I.Edvard Smith, Jan Vesterbacka, David Wullimann, Angelica Cuapio, Mira Akber, Gordana Bogdanovic, Sandra Muschiol, Mikael Åberg, Karin Loré, Margaret Sällberg Chen, Per Ljungman, Marcus Buggert, Soo Aleman, Hans-Gustaf Ljunggren
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Series:	EBioMedicine
Subjects:	SARS-CoV-2 COVID-19 mRNA vaccine Clinical study Primary immunodeficiency disease HIV
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396424004213
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXIDResearch in context

Similar Items